Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

KLH/SUBUNIT

Home DrugsKLH/SUBUNIT

KLH/SUBUNIT

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Immunogenic/therapeutic glycan compositions and uses thereof
US 11642400 B2Applicant: OBI PHARMA INCPriority: 2016
CN
US
2 publications
IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATE COMPOSITIONS AND USES THEREOF
CN 107427564 AApplicant: OBI PHARMA INCPriority: 2014
CN
Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment
US 12053514 B2Applicant: OBI PHARMA INCPriority: 2014
US
TNF-alpha (tumor necrosis factor-alpha) mutant protein and KLH (keyhole limpet hemocyanin), CTB (cholera toxin B subunit), OVA (ovalbumin) and BSA (bovine serum albumin) chemically coupled product and preparation method thereof
CN 108126197 AApplicant: SHANGHAI HYCHARM INCPriority: 2016
CN
Immune response effect generated after mouse immunization of echinococcosis-resistant recombinant vaccine P29 epitope peptide
CN 115645551 AApplicant: UNIV NINGXIA MEDICALPriority: 2022
CN